| Personalized chordoma organoids for drug discovery studies AS Ahmad Al Shihabi, Ardalan Davarifar, Huyen Thi Lam Nguyen, Nasrin ... Science Advances 8 (7), abl3674, 2022 | 37 | 2022 |
| Exploiting oncogenic drivers along the CCNG1 pathway for cancer therapy and gene therapy A Al-Shihabi, SP Chawla, FL Hall, EM Gordon Molecular Therapy-Oncolytics 11, 122-126, 2018 | 27 | 2018 |
| Initial results of a phase III investigation of safety/efficacy of nivolumab and ABI-009 (nab-sirolimus) in advanced undifferentiated pleomorphic sarcoma (UPS … VS Chua-Alcala, K Kim, N Assudani, A Al-Shihabi, D Quon, S Wong, ... Journal of Clinical Oncology 37 (8_suppl), 21-21, 2019 | 3 | 2019 |
| The landscape of drug sensitivity and resistance in sarcoma A Al Shihabi, PJ Tebon, HTL Nguyen, J Chantharasamee, S Sartini, ... bioRxiv, 2023.05. 25.542375, 2023 | 2 | 2023 |
| The SAINT: Initial results of a phase I/II study of safety/efficacy using safe amounts of ipilimumab, nivolumab, and trabectedin as first-line treatment of advanced soft tissue … SP Chawla, VS Chua-Alcala, K Kim, N Assudani, A Al-Shihabi, ... Journal of Clinical Oncology 37 (8_suppl), 22-22, 2019 | 2 | 2019 |
| A rapid platform for 3D patient-derived cutaneous neurofibroma organoid establishment and screening HTL Nguyen, E Kohl, J Bade, SE Eng, A Tosevska, A Al Shihabi, JJ Hong, ... Biorxiv, 2022.11. 07.515469, 2022 | 1 | 2022 |
| A pipeline for functional precision medicine in bone and soft tissue sarcoma organoids A Al Shihabi, PJ Tebon, J Chantharasamee, HT Nguyen, S Sartini, ... Cancer Research 82 (12_Supplement), 3078-3078, 2022 | | 2022 |
| A reconstruction of evolutionary trajectories in primary tissue and PDTOs in a patient with metastatic osteosarcoma A Davarifar, J Yanagawa, A Al Shihabi, HT Nguyen, LY Liu, A Salcedo, ... Cancer Research 82 (12_Supplement), 3071-3071, 2022 | | 2022 |
| Personalized chordoma organoids for drug discovery studies A Al Shihabi, A Davarifar, HTL Nguyen, N Tavanaie, SD Nelson, ... bioRxiv, 2021 | | 2021 |
